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The Egl gene  in Xenopus laevis is related  in sequence 
to the cdc2+ gene. We show here that the Egl  gene 
product (cdk2) possesses histone H1 protein kinase 
activity and binds to PSTAIR antibodies as well as to 
Sepharose beads linked  to  the  13-kDa product of  the 
suc 1 gene (~13”””).  Egl protein kinase is  active only 
in an M, = 200,000 complex with other proteins but is 
not associated with  any of the  three  known Xenopus 
mitotic cyclins  or  with any newly  synthesized protein 
in  egg extracts that exhibit cell cycle oscillations in 
vitro. The protein kinase  activity of Egl oscillates  in 
the mitotic cell  cycle,  being  high in “phase  and low 
in interphase. Hyperactivation of cdc2 kinase  by  the 
addition of cyclin A has no effect on the  activity  or 
oscillatory behavior of Egl. Inhibition of cdc2 kinase 
activation by emetine or RNase treatment of  oscillating 
extracts does not inhibit the  activation of Egl  but does 
block deactivation normally seen during exit from mi- 
tosis. These results indicate that Egl  is regulated by a 
cell  cycle clock independently of  cyclin and cdc2 ki- 
nase. 
Recently there  has been significant progress in  understand- 
ing the control of the cell cycle restriction  point governing 
the GZ + M transition. Biochemically, an activity first de- 
scribed in  amphibian oocytes (maturation-promoting  factor, 
MPF)’ sufficient to  stimulate  the  transition was purified and 
found to consist of a complex between p3PdC2 kinase and  B- 
type mitotic cyclins (1-8). Mitotic cyclins are proteins that 
accumulate continuously during  interphase and  that  are  then 
degraded near the metaphase/anaphase transition in mitosis. 
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In activated Xenopus egg extracts which oscillate between M- 
and S-phase, the destruction of cyclin is required for exit from 
mitosis and leads to inactivation of cdc2 kinase (9). Activation 
of cdc2 kinase is abolished by the addition of RNase to 
interphase extracts, but subsequent readdition of sea urchin 
cyclin B mRNA is sufficient to stimulate another round of 
cdc2 kinase activation and mitosis (10). Another round of 
kinase activation and inactivation can also be achieved in 
RNase-treated egg extracts by addition of cyclin protein (11, 
12). Large amounts of cyclin A protein lead to a marked 
hyperactivation of cdc2 kinase and  an  arrest  at  the metaphase 
point in the cell cycle. These results indicate that in these 
extracts cyclin is both necessary and sufficient to stimulate 
activation of cdc2 kinase and mitosis. 
Recently, a series of cDNAs was cloned by differential 
screening of mRNAs specifically adenylated and expressed in 
eggs but deadenylated and  not expressed in Xenopus embryos 
(13). One of these,  termed Egl, encodes a  protein of predicted 
M, = 34,000 that migrates on sodium dodecyl sulfate-poly- 
acrylamide gels with an  apparent M, = 32,000. It has many 
structural features similar to those of cdc2 kinase. In terms of 
overall sequence similarity, Egl is 62% identical to cdc2 kinase 
from Schizosaccharomyces pombe (14). This level of identity 
is similar to  that between human and S. pombe cdc2. Since 
the human gene can function by complementation in cdc2- 
deficient yeast (15), this level of structural conservation is 
sufficient for functional interchangeability between verte- 
brates  and yeast. Other features  shared by Egl  and cdc2 kinase 
include the presence of a TY motif in the  ATP binding site 
and a perfectly conserved 16-amino acid sequence containing 
the  PSTAIR motif, which is characteristic of all known hom- 
ologs of cdc2 kinase. Based on these conserved structural 
features, it seemed likely that  Egl was a Xenopus homolog of 
cdc2. Surprisingly, however, Egl DNA was reported to be 
unable to complement mutations in S. pombe in cdc2+ or 
mutations in the functionally  interchangeable gene CDC28 in 
the budding yeast Saccharomyces cerevisiae (14). Therefore, 
we have investigated in more detail the activity of Egl in 
Xenopus eggs in relation to cdc2 kinase. In  this paper we show 
that  Egl is a protein kinase appearing in meiosis I1 whose 
activity oscillates during the mitotic cell cycle in  a  manner 
that can be dissociated from the oscillation of cdc2 kinase. 
MATERIALS AND METHODS 
Antibody  Preparation  and Immunodetection-Antiserum was 
raised in rabbits against a 16-residue synthetic peptide of the C 
terminus of the deduced Egl sequence (THPFFRDVSRPTPHLI- 
amide), coupled to thyroglobin (14). The antibody was affinity  puri- 
fied on a  peptide-agarose column (5 mg of peptide/ml of Affi-Gel202 
(Bio-Rad) coupled using the water-soluble carbodiimide l-ethyl-3-(3- 
dimethylaminopropy1)-carbodiimide). PSTAIR antiserum was raised 
in sheep against  the  synthetic  PSTAIR peptide and affinity purified 
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in  an identical manner.  For  immunoblotting,  proteins were resolved 
on 12.5% polyacrylamide gels (16)  containing  10% glycerol, using a 
Bio-Rad minigel system, and  transferred  to nitrocellulose membranes 
a s  described previously (6).  After transfer, the membranes were 
blocked with 10% skim milk powder in phosphate-buffered saline 
(Blotto)  and  then  incubated  overnight a t  4 “C  in  Blotto with antibody, 
either an affinity-purified Egl antibody (l/zoo dilution), a PSTAIR 
antibody (%w dilution),  or an antibody raised against S. pombe cdc2 
(a  gift from K. Gould and P. Nurse,  University of Oxford; %mn 
dilution). Antibody binding was  detected  with an  appropriate  alkaline 
phosphatase-conjugated second-stage antibody (Jackson Immuno- 
chemicals). Where indicated, the  Egl  antibody was preincubated  with 
immunogen  peptide (1 pg of peptide/pg of antibody)  to block antibody 
binding to the  blotted antigen. 
diluted with 150 pl of EB buffer (20 mM Hepes, pH 7.5,15 mM MgCl,, 
In immunoprecipitation experiments, oocyte or egg extracts were 
20 mM EGTA, 1 mM dithiothreitol,  80 mM 0-glycerophosphate, 0.5 
mM phenylmethylsulfonyl fluoride, 3 pg/ml leupeptin, 50 mM NaF, 1 
mM sodium vanadate, 0.2 mM ammonium molybdate, 30 mM p-  
nitrophenol  phosphate), precleared  with  50 p1 of 50% Sepharose  CL- 
4B suspension, mixed for 30 min by gentle rotation,  and  then  centri- 
fuged 5 min. The supernatant was transferred to fresh tubes and 
incubated with 5 pg of affinity-purified Egl antibody overnight a t  
4 “C, and  the  immune complexes were precipitated with 25 pl of 50% 
protein A-Sepharose suspension  (Pharmacia  LKB Biotechnology 
Inc.), after mixing by gentle rotation for 1 h a t  4 “C. In some  cases, 
the  supernatant  after  immunoprecipitation was transferred to fresh 
tubes  and mixed with 25 p1 of 50% pl3-Sepharose  suspension for  a 
further h. In  certain  experiments,  immunoprecipitation of Egl  was 
blocked by preincubation of the  Egl  antibody with  immunogen  pep- 
tide for 1 h a t  2 pg  of peptide/pg of antibody. 
Precipitates  to be  assayed  for H1 kinase were washed  once  with 20 
mM Tris, pH 7.4, 5 mM EDTA, 100 mM NaCl, 1% Triton X-100, 
twice with same buffer containing 1 M NaCl, and twice more with 
kinase  assay buffer. Control  Sepharose CL-4B, protein A-Sepharose, 
and  pl3-Sepharose were incubated with 10 mg/ml BSA prior to use, 
t o  decrease  nonspecific binding to  the  Sepharose beads. 
Preparation ojpl3-Sepharose-pl3””’ was purified  from an  over- 
producing strain of Escherichia coli by gel filtration  on  Sepharose 
CL-GB (Pharmacia)  as described in Brizuela et al. (17). pl3EUC’ was 
coupled to activated  CH-Sepharose  (Pharmacia) a t  a  coupling density 
of 5 or 20 mg/ml Sepharose, in 0.1 M phosphate buffer, pH 6.5,  0.5 M 
NaCI, a t  4 “C for up  to 4 h. Unreacted groups were hydrolyzed with 
0.1 M Tris,  pH 8.5, and  the resin  washed as per the manufacturer’s 
instructions.  The 5  mg/ml  beads were used routinely  for H1 kinase 
assays whereas the 20 mg/ml beads were used to  precipitate  samples 
for immunoblotting. For  immunoblotting  experiments, a 0-34% am- 
monium  sulfate  fraction of a  Xenopus egg extract was diluted with 
E B  but  not precleared prior to precipitation  with  pl3-Sepharose. 
Protein Kinase Assays-The H1 kinase activity of immunoprecip- 
itates  and  pl3-Sepharose  precipitates was assayed by addition of a 
25-pl reaction mixture containing 20 mM Hepes, pH 7.5, 15 mM 
MgC12, 5 mM EGTA, 1 mM dithiothreitol, 0.2 mg/ml BSA, 0.2 mM 
ATP,  (3 cpm/fmol), 0.5 mg/ml histone H1 (prepared from calf thymus 
a s  described by Johns (18)). After incubation at  25 “C for 20 min, 
reactions were stopped by the  addition of 25 pl of 2 X Laemmli sample 
buffer, boiled for  5  min, and  run  on 12.5% polyacrylamide gels (16) 
containing 10% glycerol. H1  bands were excised from the  stained  and 
dried gels and ’lP incorporation  into H1 quantified by scintillation 
counting. Casein and MAP-2 phosphorylation were assayed using 
similar conditions, substituting for H1 either 1 mg/ml a-casein 
(Sigma) or 0.1 mg/ml  purified MAP-2 (gift  from T. Sturgill,  Univer- 
sity of Virginia). Lamin phosphorylation was performed using 100 
pg/ml purified rat liver lamins A and C (gift from J. Glass  and L. 
Gerace, Scripps Institute) in 20 mM Tris,  pH 8.0, 15 mM MgC12, 2 
mM EGTA, 1 mM dithiothreitol, 200 mM KCI. Gels were autoradi- 
ographed prior to excision of the  appropriate band. 
Preparation of Oocytes and Egg Extracts-Unfertilized eggs were 
obtained from  female  Xenopus lueuis frogs  (Xenopus I,  Ann Arbor, 
Michigan)  primed  with 75 units of pregnant mare’s serum  gonadotro- 
pin 3 days prior to  the  experiment  and induced to  ovulate by the 
injection of 550 units of human chorionic  gonadotropin 14-16 h prior 
to  the experiment.  High  speed supernatant  and  ammonium  sulfate 
fractions were prepared  from the egg crushate as described  in Lohka 
et a!. (1). Oscillating Murray  extracts were prepared from  unfertilized 
eggs as described  in Roy et al. (12).  Aliquots (5 pl) were removed a t  
times indicated in  the figure legends and  then  stored a t  -70 “C  until 
immunoprecipitations were performed. Spodoptera jrugiperdu (Sf9) 
a b 
1 2 3 4 5 6  
FIG. 1. Immunoprecipitation of Egl.  a, the 32-kDa, “S-labeled 
in uitro translation  product from Egl mRNA (lane I ) was immuno- 
precipitated by Egl antibody, without (lune 2) or with (lane 3) 
preincubation of the  antibody  with immunogen  peptide. b, an aliquot 
of a 0-34% ammonium  sulfate  fraction from unfertilized eggs (200 pg 
diluted to 100 pl with EB) was incubated with preimmune serum 
(lane 4 ) ,  with Egl antibody  (lane 5), or with antibody blocked with 
immunogen peptide  (lane 6 ) .  The autoradiograph of H1 phosphoryl- 
ated by the  immunoprecipitates is  shown. 
cell lysates containing baculovirus-expressed clam cyclin A were 
prepared as described in Roy et al. (12). For oocyte maturation 
experiments, frogs were primed  with 35 IU of pregnant mare’s serum 
gonadotropin 3 days prior to removal of the ovary, and stage VI 
oocytes were manually dissected out of their follicular envelopes. 
Oocyte maturation was induced by the  addition of progesterone to 10 
p~ in medium OR-2  supplemented with 10 mM sodium  bicarbonate, 
pH 7.8, 0.1 mg/ml BSA, and 1 mM sodium pyruvate. Samples of 
oocytes were removed a t   the  indicated times, homogenized in EB (10 
plloocyte), centrifuged  for  5  min in a  microcentrifuge, and  the super- 
natants  stored  at -70 “C until  further analysis. 
I n  Vitro Transcription and  Translation of E@-A 950-base pair 
fragment,  corresponding to  the complete  open-reading frame of Egl, 
was generated by polymerase chain reaction using Egl cloned in 
PBluescript KS (14) and two synthetic oligonucleotides for  primers. 
The first oligonucleotide was homologous to  the  first ATG region of 
the gene containing an NcoI site,  and  the second oligonucleotide was 
homologous to the last 5 codons of the open reading frame and 
contained an XbaI site 3’ of the homologous sequence. This fragment 
was then subcloned into  the  pEPEX vector’ between the NcoI and 
XbaI sites flanked, respectively, by the 5’ and 3’ regions of the 
Xenopus @-globin gene. The NcoI/KpnI fragment generated by polym- 
erase  chain reaction  was then replaced by the  same  fragment from 
the Bluescript vector, which reduced the actual part of the gene 
generated by polymerase chain reaction to 150 base pairs. I n  uitro 
transcription from the  T7 promoter was performed on a  linearized 
template using an  in uitro transcription  system from Stratagene. In  
uitro translation of the capped  mRNA was done  in  reticulocyte  lysates 
(Promega) according to  the manufacturer’s instructions. 
RESULTS 
Egl Is Not Detectable in Purified MPF-Much  of the 
previous work identifying cdc2 kinase in MPF from  various 
species and in extracts of various cell types has relied on 
immunoprecipitation and immunoblotting  of  preparations 
with anti-PSTAIR antibody, based on the assumption this 
motif is present only in cdc2 homologs.  However, the presence 
of the PSTAIR sequence  in both Egl and cdc2+ suggests  that 
such antibodies recognize both kinases. Therefore, to generate 
a reagent  specific for Egl, an antiserum  was  raised  against a 
16-residue synthetic peptide  corresponding to residues 282- 
297 in the C-terminal  region  of the Egl protein, a region  that 
displays  no  sequence similarity to ~34‘~‘’ from  various  species 
(14)) although the sequence of Xenopus ~34‘~‘’ has not yet 
been reported. The affinity-purified Egl antibody immuno- 
precipitated the 35S-labeled 32-kDa product of the in vitro 
translation of Egl mRNA (Fig. 1, lanes 2-3). Egl immuno- 
precipitates from the 0-34% ammonium sulfate fraction of 
unfertilized eggs contained a histone H1 protein  kinase activ- 
ity, which  was  reduced to background levels by  preincubating 
the antibody with the immunogen  peptide (Fig. 1, lanes 4-6). 
The kinase  phosphorylated both serine  and  threonine  residues 
J. Gautier,  manuscript in preparation. 
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but not  tyrosine  in H1  (data  not shown). In  the same ammo- 
nium  sulfate  fraction Egl antibody recognized a 32-kDa poly- 
peptide by immunoblotting but did not recognize any poly- 
peptides in highly purified MPF (Fig. 2, lunes 13) ,  and no 
H1 kinase activity was associated with Egl immunoprecipi- 
tates from purified MPF fractions (data not shown). The 
other (MI = 20,000) band detected by the antibody  in the 0- 
34% ammonium sulfate  fraction and blocked by the immu- 
nogen peptide, was not consistently observed and was absent 
in partially purified fractions of Egl. 
Similar experiments were carried out with an antiserum 
raised  against  full-length bacterially expressed S. pombe 
~34'~''.  This antiserum  blotted  a 34-kDa polypeptide in both 
the 0-34% ammonium sulfate  fraction and in purified MPF 
preparations (Fig. 2, lanes 4-6) .  This band has been identified 
previously as Xenopus ~ 3 4 ' ~ ' '  on  the basis of immunoblotting 
and immunoprecipitation with anti-PSTAIR antibody (6). 
The antibody could, however, detect Egl  in  the concentrated 
ammonium sulfate  fraction (lane 4 ) )  most likely because of 
the close sequence similarity between cdc2 and  Egl. Th,ere- 
fore, purified Xenopus MPF  contains cdc2 kinase but  not  the 
Egl kinase (cdk2). 
The  H1 kinase activity  associated with Egl accounted for 
only  a  small  proportion of the  total  H1 kinase  activity in  the 
0-34% ammonium sulfate fraction of unfertilized eggs, as 
immunodepletion of >80% of the  Egl depleted only 5% of the 
H1 kinase activity (data not shown). The Egl protein is 
present at  5-10%  of the abundance of ~34 '~ ' '  in egg extracts 
as determined by densitometry of immmunoblots of egg ex- 
tracts using the PSTAIR antibody, which recognizes the 
conserved PSTAIR epitope in both Egl  and  ~34'~' '  (Fig. 2, 
lune 7). Several proteins were tested as substrates for the 
immunoprecipitated Egl kinase. MPF phosphorylated  puri- 
fied rat liver lamins  A and C ,  whereas these proteins were not 
substrates for Egl (Fig. 3, lanes 1-3). Glycogen synthase  and 
tyrosine hydroxylase were not phosphorylated by either MPF 
or  Egl. A  synthetic  peptide based on the consensus recogni- 
tion sequence in H1 for growth-associated (cdc2) kinase 
(KTPK),  and  an analog with the  determinant proline  substi- 
tuted with glycine (19), were tested for their ability to compete 
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FIG. 2. Egl is not present in  purified MPF. Either a 0-34% 
ammonium sulfate fraction from unfertilized egg extracts (100 pg; 
lanes I, 3 , 4 , 6 ,  and 7) or highly purified MPF (100 ng; lanes 2 and 5 )  
was subjected to Western  blotting, as described under  "Materials and 
Methods," with unblocked or peptide-blocked antibodies, as indi- 
cated.  The upper arrow indicates the position of ~ 3 4 ' ~ ' ~  whereas the 
lower arrow indicates Egl. No bands were detected in lane 2 even 
with prolonged incubation in the color reagent. Ab, antibody. 
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FIG. 3. Egl kinase and MPF phosphorylate distinct sub- 
strates. Panel a, purified rat liver lamins A and C (gift of  L. Gerace, 
Scripps) were phosphorylated with purified MPF (lane 1 )  and  Egl 
blocking (lane 3 ) .  The  identity of the labeled band in the blocked Egl 
immunoprecipitates without peptide blocking (lane 2 )  or with peptide 
lane  is  unknown.  Similar  activities of Egl  and  MPF kinase activity 
toward H1 were used; the  lamins (100 pglml) were phosphorylated at  
1% of the  rate of H1 (0.5 mg/ml) by MPF. Panel b, histone H1 was 
phosphorylated by Egl immunoprecipitates (lanes 4, 7, and IO), 
peptide-blocked Egl immunoprecipitates (lanes 5, 8, and 111, or 
purified MPF (lanes 6, 9, and 12) in the absence (lanes 4-6) or 
presence of 100 p~ H1 peptide (AKAKKTPKKAK, lanes 7-9) or 
glycine-substituted H1 peptide  (AKAKKTGKKAK, lanes 10-12). 
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FIG. 4. Egl specifically binds  to p13""". Control Sepharose 
CL-4B (lanes 1 and 4 )  or pl3-Sepharose (50 pl of 50% suspension; 
lanes 2,3,5,  and 6)  was incubated  with the 0-34% ammonium  sulfate 
fraction of unfertilized egg extracts (350 pg diluted to 200 pl with EB) 
for 1 h, washed, and  then eluted with 2 X Laemmli sample buffer. 
The blotted proteins were incubated with the antibodies as indicated 
under  "Materials and Methods." Ab, antibody. 
with H1 for phosphorylation by Egl  and purified MPF.  MPF 
H1 phosphorylation was efficiently competed with consensus 
peptide and much less efficiently by the glycine-substituted 
analog whereas neither peptide had  any detectable effect on 
phosphorylation of H1 by Egl (Fig. 3). 
Egl Binds top1J"""The 13-kDa suc 1 gene product from 
S. pombe has been shown to  interact directly with ~34'~'' from 
all species so far examined, and when covalently attached to 
Sepharose beads it  has been used widely as a "highly specific" 
reagent for the precipitation of ~34'~''  and  its complexes. The 
high degree of sequence identity between Egl and ~ 3 4 ' ~ ' ~  
prompted us  to investigate whether p13"" ' also binds the  Egl 
protein kinase. On immunoblots comparing control and p13- 
Sepharose-bound  proteins from the 0-34% ammonium sulfate 
fraction of unfertilized egg extracts, ~34 '~ ' '  was detected only 
in  eluates from pl3-Sepharose (Fig. 4, lanes 4-6). The 32-kDa 
Egl  band was also detected only in pl3-Sepharose eluates, 
and recognition of the band was specifically blocked by prein- 
cubation of the antibody with immunogen peptide (lanes 1- 
3). Egl is thus  the  first kinase in  addition to cdc2  which can 
be demonstrated  to  bind specifically p13"" '. Recently, a Xen- 
opus homolog of suc 1 has been cloned in our laboratory and 
also found to bind Egl with high affinity? 
T. Izumi and B. Gabrielli, unpublished data. 
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Egl Exists as High and Low Molecular Weight Form-  
High speed supernatant from unfertilized Xenopus egg ex- 
tracts was fractionated on a Sephacryl S-200 column and 
assayed for H1 kinase activity  in Egl immunoprecipitates and 
in pl3-Sepharose  precipitates of Egl-depleted fractions. p13- 
Sepharose  precipitated  a  broad band of H1 kinase  activity, 
with the peak  activity  eluting  with an M ,  of 140,000 (Fig. 5a). 
In  contrast,  the  H1 kinase specifically associated with Egl 
eluted as a peak of M, 200,000. Immunoblotting of these 
fractions with antibodies to  Egl  and ~ 3 4 ' ~ ' ~  showed that  the 
abundance of the  ~34'~' '  band corresponded to  the peak of 
pl3-Sepharose-precipitatedH1 kinase (Fig. 5b), and  the  abun- 
dance of the  Egl polypeptide corresponded to  the level of Egl 
H1 kinase activity (Fig. 5c). The casein kinase  activity of p13- 
Sepharose  precipitates followed the  H1 kinase profile exactly 
(Fig. 5d).  The antibodies also recognized a large pool of ~ 3 4 ' ~ ' ~  
and  Egl which eluted with an M, of  20,000-50,000, most likely 
monomeric forms in which no  H1 kinase  activity was detected. 
This result  indicates that in Xenopus the monomeric forms 
of both Egl  and ~ 3 4 ' ~ ' ~  are catalytically inactive. In  contrast, 
in HeLa cells the monomeric form of ~34'~' '  has been reported 
to be an active casein kinase  with  a  different substrate spec- 
ificity compared with the high molecular weight complex (8, 
20). This  latter result may, however, reflect the nonspecific 
binding of a low molecular weight casein kinase to Sepharose 
beads, as we found that control  Sepharose beads alone  non- 
specifically adsorbed a low level of casein kinase activity 
present in low molecular weight fractions. Sepharose beads 
not blocked with 10 mg/ml  BSA prior to use precipitated high 
levels of both casein and H1 kinase activity from column 
fractions. 
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FIG. 5. Chromatography of Xenopus egg extract on  Sepha- 
cry1 5-200. High  speed supernatant (7 mg  of unfertilized egg extract 
protein) was applied to a Sephacryl S-200 column (70 X 1 cm) 
equilibrated in 20 mM Tris, pH 7.0, 5 mM MgC12, 2 mM EGTA, 1 mM 
dithiothreitol, 0.15 M NaCI, 1 mM CHAPS, and eluted at  a flow rate 
of 15 ml/h. Fractions of 1.3 ml were collected. Aliquots (200 pl)  of 
the indicated fractions were incubated first with control Sepharose 
CL-4B and then with either pl3-Sepharose (filled circles) or Egl 
antibody (open  circles) and assayed for H1 kinase activity (panel  a). 
The pl3-Sepharose precipitates were also assayed for casein kinase 
( C K )  activity (panel d ) .  The remainder of each fraction was precipi- 
tated with 20% trichloroacetic acid using 50  pg of BSA as  a  carrier. 
The washed precipitates were analyzed on 12.5% polyacrylamide gels, 
transferred to nitrocellulose membranes, and blotted with either anti- 
cdc2 antibody (panel b )  or Egl antibody (panel c).  Only the  pertinent 
region of the blot is shown. The positions of elution of protein 
standards are indicated: ferritin, 440 kDa; alcohol dehydrogenase, 145 
kDa; ovalbumin, 43 kDa; and cytochrome c, 20 kDa. 
Synthesis and Activation of EgI during Meiotic Maturation 
of Oocytes-Since the mRNA for Egl becomes specifically 
polyadenylated and recruited onto polysomes during oocyte 
maturation (14), we initially examined extracts of maturing 
oocytes for the synthesis of Egl protein and activation of Egl 
protein kinase activity. The  Egl protein is present at  very 
low levels in resting oocytes and is synthesized during matu- 
ration  until GVBD, where it accumulates to levels 4-5-fold 
greater than present in resting oocytes. Very little more 
accumulates  during progression to meiosis I1 (Fig. 6, inset). 
The kinase activity of Egl did not increase significantly until 
after GVBD, as oocytes entered  the meiosis I1 cell cycle, and 
this elevated activity was maintained  during  cytostatic factor 
arrest  at metaphase of meiosis I1 (Fig. 6). Ablation of Egl 
mRNA  using Egl antisense oligonucleotides resulted in the 
complete inhibition of Egl protein accumulation but had  no 
effect on cdc2 H1 kinase  activation or white spot formation 
on entry into meiosis I (data not shown). These results 
demonstrate that Egl H1 kinase has no essential role in 
maturation to meiosis I. Likewise, microinjection of Egl 
mRNA (50 ng/oocyte), which resulted  in the massive over- 
expression of Egl protein, also did not affect the rate of 
progesterone-stimulated oocyte maturation  to meiosis I and 
did not affect the timing or magnitude of Egl H1 kinase 
activation (data  not shown). 
Egl H1 Kinase Activity  Oscillates during the Embryonic Cell 
Cycle-Inasmuch as  Egl  and ~ 3 4 ' ~ ' ~  are similar  in sequence, 
in possessing H1 kinase activity, in binding p13"" ', and in 
forming high molecular weight complexes, it was important 
to evaluate  whether Egl, like cdc2 kinase, underwent changes 
in activity during the cell cycle. The  H1 kinase activity of 
Egl during the embryonic cell cycle was investigated by 
assaying Egl immunoprecipitates from egg extracts  that os- 
cillate spontaneously between mitosis and DNA synthesis 
(10, 12). Since Egl contributed less than  5% of H1 kinase 
activity present on p13 beads, the cdc2 H1 kinase was assayed 
as the total pl3-Sepharose-precipitated H1 kinase present 
after  Egl immunoprecipitation (cf.  Fig. 6). The  Egl antibody 
was used in antibody excess, 5 pg  of antibody/5 p1 of extract, 
depleting >80% of the  Egl protein, whereas the  pl3-Sepha- 
rose did not clear the cdc2 H1 kinase from the extract. 
Therefore, the ratio of kinase activities  precipitated by these 
two reagents did not reflect the actual ratio of activities  in 
the extracts. 
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FIG. 6. Synthesis and activation of Egl during  oocyte  mat- 
uration. Stage VI oocytes were  exposed to progesterone, and samples 
of 20 oocytes were  removed at  the indicated times and assayed  for 
H1 kinase activity in Egl immunoprecipitates (circles) or in p13- 
Sepharose precipitates  after depletion of Egl (squares). GVBD oc- 
curred at  3.5 h (arrow). Inset, oocyte samples were taken from resting 
(lane I ) ,  GVBD (lane 2) ,  and meiosis I1 (lane 3) oocytes and immu- 
noblotted for Egl protein. 
Oscillatory Activity of a cdc2-Related Kinase 1973 
The  Egl  H1 kinase oscillated in a  manner  similar to  that 
of cdc2 kinase (Fig. 7) although the activity varied only 2-3- 
fold compared with 5-10-fold for cdc2 kinase. Preincubation 
of the Egl antibody with immunogen peptide completely 
blocked precipitation of the  H1 kinase activity (cf. Fig. lb, 
lane 6). The oscillation of Egl  H1 kinase was not caused by 
changes  in the level of the  Egl protein  during the cycle, as 
immunoblotting of high speed supernatant from ionophore- 
activated eggs showed the abundance of Egl did not change 
through  the  first mitotic cycle, which was also the case for 
~ 3 4 ' ~ ' '  (data not  shown). 
Cyclins Are  Not Associated with Egl-The evidence that 
the  Egl  H1 kinase is in a high molecular weight complex and 
that its activity oscillates during the embryonic cell cycle 
raises the question of whether Egl associates  with the mitotic 
cyclins, which are  in  part responsible for the oscillation of the 
cdc2 kinase activity (10, 12). Recently Minshull et al. (21) 
used the  Egl antibody described here to show that immuno- 
precipitates of Xenopus cyclins A, B1, and B2 from unfertil- 
ized eggs did not contain Egl.  PSTAIR antibody  blotting of 
the same cyclin immunoprecipitates showed that only a 34- 
kDa  band corresponding to ~ 3 4 ' ~ ' '  was present, and no 32- 
kDa band could be detected. In  the same experiments the 
PSTAIR antibody did recognize the product of in  vitro trans- 
lated Egl, which corresponds to a minor 32-kDa band in crude 
egg extracts (see also Fig. 2, lane 4 ) .  Finally, in this laboratory, 
no 35S-labeled bands were specifically immunoprecipitated by 
Egl antibodies from either oscillating extracts  or [35S]methi- 
onine-labeled  maturing oocytes, even with exposure of gels 
for much longer periods than required to visualize cyclins 
bound to pl3-Sepharose or newly synthesized Egl during 
progesterone-stimulated oocyte maturation  (data  not shown). 
The absence of a 35S-labeled Egl band in egg extracts is 
consistent with the deadenylation of Egl mRNA reported to 
occur upon activation of  eggs (14). 
HI Kinase  Activity of Egl Oscillates Independently of 
p34'd'2-Further evidence for the lack of direct  interaction of 
cyclins with Egl comes from the finding that inhibiting  pro- 
tein synthesis in oscillating extracts, which inhibits cyclin 
accumulation and blocks progression of the cell cycle (10,12), 
had no effect on activation of Egl kinase whereas activation 
of cdc2 kinase was abolished. In emetine-treated oscillating 
extracts, the activation of Egl kinase paralleled controls, but 
the decrease in activity normally accompanying exit from 
mitosis was inhibited (Fig. 8a). In  contrast, activation of cdc2 
kinase measured on pl3-Sepharose beads was reduced to 
background levels in  these emetine-treated  extracts. Identical 
results were obtained with RNase-treated extracts  (data not 
shown). Thus  the decrease in Egl kinase activity during exit 
from mitosis may  be dependent on a newly synthesized factor 
whereas the inactivation of cdc2 kinase in similar extracts 
requires only the activated complex resulting from prior syn- 
thesis of cyclin (10, 12). 
The addition of exogenous clam cyclin A protein to an 
oscillating Murray extract causes concentration-dependent 
hyperactivation of cdc2 kinase and  attenuates  the reduction 
of H1 kinase activity and  the destruction of cyclins upon exit 
from "phase (Fig. 8b and Ref. 12). In  contrast,  the activity 
and period of oscillation of Egl H1 kinase were virtually 
unaltered by the addition of excess cyclin (Fig. 8b). Moreover, 
35S-labeled clam cyclin A could be precipitated from oscillat- 
ing extracts with pl3-Sepharose (12), indicating the direct 
association of the clam cyclin with ~ 3 4 ' ~ ' ~ ,  whereas none was 
associated with Egl immunoprecipitates (data not shown). 
These results support the lack of association of Egl with 
cyclins G2/M in Xenopus. Perhaps more interestingly,  these 
data show that the oscillation of Egl H1 kinase can be 
dissociated from the oscillation of cdc2 kinase activity. 
DISCUSSION 
There  are a number of previously identified protein kinases 
with some level of sequence similarity to  ~34'~' '  (22-29). Most 
of these  proteins have only 30-50% identity with ~34'~'' from 
various sources, much lower than  that evident with the  Egl 
gene product and  the closely related Dm cdc2c  gene product 
from Drosophila (30). More specifically, no other kinase has 
previously been found to contain a complete PSTAIR se- 
quence, which has been thought to be unique to cdc2 homo- 
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FIG. 7. Egl protein kinase  activity  oscillates in the embry- 
onic cell cycle. Samples from oscillating Murray extracts of acti- 
vated eggs prepared as described under "Materials and Methods" 
were assayed for the H1 kinase activity of Egl immunoprecipitates 
(lower  panel) or of cdc2 kinase in pl3-Sepharose  precipitates of the 
supernatant (upper  panel) after immunoprecipitation. Control exper- 
iments showed that  the kinase activity in the  Egl immunoprecipitates 
was completely blocked by preincubation of the antibody with the 
immunogen peptide (data not shown). 
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FIG. 8. Dissociation of Egl and cdc2 kinase oscillations. A, 
protein synthesis inhibitors do not affect Egl kinase activation. 
Aliquots were  removed from either  untreated (open squares) or eme- 
tine-treated (filled  circles) oscillating extracts at  the indicated times, 
diluted, and precipitated first with Egl antibody (lower  panel) and 
then with p13"" "Sepharose as a measure of cdc2 kinase (upper 
panel). The precipitates were then assayed for H1 kinase activity as 
described under "Materials and Methods." b, hyperactivation of cdc2 
by mitotic cyclin A does not affect Egl kinase. Aliquots were  removed 
from either control (open squares) extracts or extracts to which 
baculovirus-produced clam cyclin A (final concentration of 250 nM 
in the extract) was added (filled  circles). Aliquots were analyzed as  in 
panel a. Other controls utilizing addition of Sf9 lysates of cells infected 
with wild-type haculovirus did not activate ~34'~' '  (12) and had no 
effect on Egl activity (not shown). 
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logs, although PH085  has identity in 14 of the 16 residues in 
the PSTAIR sequence (24). The function of this conserved 
sequence is unknown although microinjection of the synthetic 
PSTAIR peptide increases the  rate of progesterone-induced 
oocyte maturation in Xenopus (6) and induces maturation 
and a Ca'+ flux in  starfish oocytes (3,31). 
The 13-kDa product of the s u c  1 gene of S. pombe, desig- 
nated p13"" I ,  has been shown to associate directly with the 
cdc2 kinase complex from a  variety of sources and  has also 
been used widely to prepare "specific" affinity resins for 
~ 3 4 ' ~ ' ~ .  In genetic experiments, the suc 1 gene has been shown 
to rescue some cdc2+ mutants,  and overexpression causes a 
delay in exit from G2 (32,33). In  vitro studies have also shown 
that high concentrations of  p13""' (>0.5 NM) directly stabilize 
thermolabile cdc2 kinase (34) and inhibit  activation of MPF 
in Xenopus egg extracts at  a step prior to tyrosine dephos- 
phorylation of ~ 3 4 ' ~ '  (8,35).  Other evidence has suggested a 
role for the suc 1 gene product in exit from mitosis (34) 
whereas the multiple cell growth and cell division cycle- 
blocked phenotypes observed in suc 1 null mutants suggests 
that pl?"' acts at  a number of important cellular control 
points, probably interacting  with several cellular components 
(32). Certainly, only a  small  proportion of the cellular pool of 
ply" ' is associated with the cdc2 kinase complex in S. pombe 
and HeLa cells (17,36). The direct  interaction of p13" with 
the  Egl kinase is an example of a suc 2 function  independent 
of ~ 3 4 ' ~ ' ~ .  Although the function of p13"" binding to either 
Egl or ~ 3 4 ' ~ '  is unknown at present, it may represent a 
common element involved in  the regulation of both  Egl  and 
p3PdC2 activities. Clearly, experiments that rely solely on 
p13""' ' binding to monitor cdc2 kinase may lack specificity. 
The ability to uncouple the cdc2 and  Egl kinase oscillations 
by the addition of clam cyclin or with protein synthesis 
inhibitors is an interesting result. Similar findings have been 
reported for nucleoside diphosphate kinase activity and CO, 
production in S. pombe, which oscillate with regular periods 
during the normal cell  cycle, and whose period of oscillation 
is little affected in cell cycle-blocked cdc2 mutants (37, 38). 
The oscillation of cdc2 kinase activity has been correlated 
with many measures of cell cycle progression, including the 
surface contraction waves described by Hara et al. (39), and 
the ability to promote GVBD in resting oocytes and nuclear 
envelope breakdown in  a cell-free extract.  These  functional 
assays may only reflect phosphorylation by cdc2 kinase of 
lamins, microtubule-associated proteins, myosin light chains, 
nucleolar proteins, and histones, which function to reorganize 
the cell structurally in preparation for mitosis (40). The 
relatively low abundance of Egl kinase and  its inability to 
phosphorylate lamins suggest that  it does not have a major 
role in the cytoskeletal rearrangements at  mitosis. The fact 
that  Egl continues to oscillate when the cdc2 kinase is hyper- 
activated suggests that  the clock controlling Egl activation is 
not perturbed by reactions involved in the  structural reorga- 
nization of the cell for mitosis, at  least  in the in  vitro system 
used in  these experiments. 
These  results raise the question of what  controls the oscil- 
latory activity of Egl.  The timing of activation of ~34"~" '  can 
be controlled by cyclin accumulation in in  vitro systems (10- 
12). However, the addition of unreplicated DNA to Xenopus 
egg extracts  demonstrated that whereas cyclin accumulation 
and association with p3PdC2 occurred unimpeded, this was not 
sufficient to activate cdc2 kinase or cause entry  into mitosis 
(41). Thus more fundamental factors than cyclin such as 
cdc25, weel, and suc 1 control cell cycle progression, and these 
appear  to regulate the oscillation of MPF activity by regulat- 
ing  the tyrosine phosphorylation state of ~ 3 4 ~ ~ ~ '  complexed
with cyclin (5, 11, 35,  42,  43). The finding that  Egl activity 
oscillates with  a period similar to  that of  cdc2 and  the presence 
of a T14Y15 motif in the  Egl  ATP binding site  demonstrated 
to be the tyrosine phosphorylation site in S. pombe (44) 
suggest the possibility Egl is also controlled by cdc25 and 
weel. Preliminary  experiments indicate Egl is a phosphopro- 
tein  and  that  its phosphate content does change during the 
mitotic cycle;  however, the residues phosphorylated have not 
yet been identified.4 
It is surprising that no 35S-labeled proteins were specifically 
immunoprecipitated with Egl from either progesterone-ma- 
tured oocytes or cycling egg extracts. That  Egl is an active 
kinase only as a high molecular weight complex suggests that 
it must  bind to  other proteins which act  as positive regulatory 
subunits. The data presented here and elsewhere (11, 21) 
indicate that the known mitotic cyclins are not associated 
with Egl  in Xenopus eggs. This lack of association probably 
accounts for the inability of Egl  to complement certain cdc2/ 
CDC28 mutants in yeast (14). No other good candidate for an 
Egl regulatory subunit is apparent. It must, however, be 
metabolically stable and is probably present  in lower abun- 
dance than  Egl itself, as judged by the large pool  of monomeric 
inactive Egl protein. This subunit conceivably could regulate 
Egl activity via directed phosphorylation/dephosphorylation 
of the  Egl subunit, analogous to  the cyclin B-directed phos- 
phorylation/dephosphorylation of ~ 3 4 ' ~ ' ~ ,  which is prerequi- 
site for activation of cdc2 kinase (11). Purification of the high 
molecular weight form of Egl  and characterization of associ- 
ated proteins will be required to evaluate  these possibilities. 
The function of Egl is currently unknown. However, its 
relatively low abundance,  activation in meiosis 11, and inabil- 
ity  to phosphorylate a structural protein substrate of cdc2 
kinase suggest that  it may have a more restricted role in cell 
cycle regulation than cdc2. The distinguishing feature between 
meiosis I and I1 is that metaphase arrest occurs only at  meiosis 
11. This arrest function has been ascribed to a cytostatic 
factor, which was recently identified as containing the product 
of the proto-oncogene c-mos (45). However, c-nos has also 
been demonstrated to be present and necessary for oocyte 
maturation  to meiosis I (46), where it  has no  metaphase arrest 
function and where Egl kinase is inactive. It is possible that 
Egl may cooperate with c-mos to promote the meiosis I1 
arrest,  and we are currently  investigating this interaction. 
The activation of Egl  at meiosis I1 may also be preparatory 
for a  critical  function  during the rapid embryonic cell cycles 
after fertilization which consist  predominantly of DNA rep- 
lication and mitotic division. In yeast, CDC28 has a start 
function governing entry  into DNA synthesis which is asso- 
ciated  with  a relatively low level of H1 kinase activity (47). 
Because of evolutionary specialization, this  start function may 
no longer be controlled by ~34'~' '  in higher eucaryotes but 
conceivably may  be controlled by a closely related gene prod- 
uct  such as  Egl.  In yeast as well as higher cells, the  Gl/start 
function of cdc2 is correlated with a novel class of proteins 
designated G1 cyclins (47-49).  If Egl is involved in  control of 
DNA replication, then one could predict that  it will associate 
with a form of Gl/S cyclin distinct from the mitotic cyclins. 
The  H1 kinase  activity of Egl, being highest at metaphase 
and lowest (yet not zero) at  interphase, possibly argues against 
a DNA replication function. However, it  cannot  yet be ex- 
cluded that metaphase  activation reflects preparation of Egl 
for the next  round of DNA replication in  the abbreviated cell 
cycles in embryos. 
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